<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><link type="text/css" rel="stylesheet" href="resources/sheet.css" >
<style type="text/css">.ritz .waffle a { color: inherit; }.ritz .waffle .s1{border-left: none;background-color:#ffffff;}.ritz .waffle .s11{background-color:#f9f9f9;text-align:left;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:top;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s9{background-color:#ffffff;text-align:left;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:top;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s10{border-right: none;background-color:#ffffff;text-align:left;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:top;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s0{border-right: none;background-color:#ffffff;text-align:left;color:#007bff;font-family:'Arial';font-size:10pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s3{border-right: none;background-color:#ffffff;text-align:left;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s4{border-left: none;border-right: none;background-color:#ffffff;}.ritz .waffle .s6{border-bottom:1px SOLID #dee2e6;background-color:#ffffff;}.ritz .waffle .s13{background-color:#ffffff;text-align:left;color:#444444;font-family:'Arial';font-size:12pt;vertical-align:top;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s8{border-right: none;border-bottom:1px SOLID #dee2e6;background-color:#d9edf7;text-align:left;font-weight:bold;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s14{border-right: none;background-color:#ffffff;text-align:left;text-decoration:underline;-webkit-text-decoration-skip:none;text-decoration-skip-ink:none;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:top;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s2{background-color:#ffffff;text-align:left;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s7{border-bottom:1px SOLID #dee2e6;border-right:1px SOLID #dee2e6;background-color:#d9edf7;text-align:left;font-weight:bold;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s5{border-bottom:1px SOLID #dee2e6;background-color:#ffffff;text-align:left;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:bottom;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}.ritz .waffle .s12{border-right: none;background-color:#f9f9f9;text-align:left;color:#444444;font-family:'docs--apple-system',Arial;font-size:12pt;vertical-align:top;white-space:nowrap;direction:ltr;padding:2px 3px 2px 3px;}</style><div class="ritz grid-container" dir="ltr"><table class="waffle" cellspacing="0" cellpadding="0"><thead><tr><th class="row-header freezebar-origin-ltr"></th><th id="1050178152C0" style="width:306px;" class="column-headers-background">A</th><th id="1050178152C1" style="width:100px;" class="column-headers-background">B</th></tr></thead><tbody><tr style="height: 20px"><th id="1050178152R0" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">1</div></th><td class="s0 softmerge" dir="ltr"><div class="softmerge-inner" style="width:404px;left:-1px">HIV in Pregnancy (antiretroviral therapy in pregnancy)</div></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1050178152R1" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">2</div></th><td class="s2"></td><td></td></tr><tr style="height: 20px"><th id="1050178152R2" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">3</div></th><td class="s2" dir="ltr">Antiretroviral therapy (ART) in pregnancy</td><td></td></tr><tr style="height: 20px"><th id="1050178152R3" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">4</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:404px;left:-1px">ART is mostly unlicensed for use in pregnancy</div></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1050178152R4" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">5</div></th><td class="s2" dir="ltr">Zidovudine is licensed in the third trimester</td><td></td></tr><tr style="height: 20px"><th id="1050178152R5" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">6</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:804px;left:-1px">Women who conceive on effective combination of ART (cART) should continue throughout pregnancy</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R6" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">7</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:604px;left:-1px">Atypical regimes such as protease inhibitor (PI) monotherapy should be modified</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R7" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">8</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:604px;left:-1px">Zidovudine is now rarely used as part of cART due to concerns about toxicity</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R8" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">9</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:804px;left:-1px">Data shows no difference in pregnancy outcomes between zidovudine-based and zidovudine-sparing cART</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R9" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">10</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:904px;left:-1px">Data does not support increased risk of congenital malformations with cART so far but some agents have insufficient data</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R10" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">11</div></th><td class="s2"></td><td></td></tr><tr style="height: 20px"><th id="1050178152R11" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">12</div></th><td class="s2" dir="ltr">Starting cART if not taking</td><td></td></tr><tr style="height: 20px"><th id="1050178152R12" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">13</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:804px;left:-1px">All pregnant women, including elite controllers, should start cART during pregnancy and continue lifelong</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R13" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">14</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:804px;left:-1px">BHIVA recommend treatment of all people living with HIV regardless of CD4 cell count or clinical status</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R14" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">15</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:604px;left:-1px">All women should have commenced ART at the latest by week 24 of pregnancy</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R15" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">16</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1204px;left:-1px">Evidence mounting that cART is safe in the first trimester but due to theoretical risks initiation of cART is often delayed until the start of the second trimester.</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R16" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">17</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:504px;left:-1px">Current advise is to start ART at start of second trimester*</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R17" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">18</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:804px;left:-1px">*If a women presents with opportunistic infection treatment should not be delayed due to pregnancy</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R18" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">19</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:804px;left:-1px">*Start in 1st trimester if VL &gt;100,000 HIV RNA copies/mL and/or CD4 cell count is less than 200 cells/mm³</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R19" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">20</div></th><td class="s2"></td><td></td></tr><tr style="height: 20px"><th id="1050178152R20" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">21</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:404px;left:-1px">Deciding Mode of delivery in women taking cART</div></td><td class="s1"></td></tr><tr style="height: 20px"><th id="1050178152R21" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">22</div></th><td class="s3 softmerge" dir="ltr"><div class="softmerge-inner" style="width:604px;left:-1px">Viral load should be checked at 36 weeks then delivery planned as follows:</div></td><td class="s4"></td></tr><tr style="height: 20px"><th id="1050178152R22" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">23</div></th><td class="s5"></td><td class="s6"></td></tr><tr style="height: 20px"><th id="1050178152R23" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">24</div></th><td class="s7" dir="ltr">Viral Load at 36 weeks</td><td class="s8 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Recommendation</div></td></tr><tr style="height: 20px"><th id="1050178152R24" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">25</div></th><td class="s9" dir="ltr">&lt; 50 HIV RNA copies/mL</td><td class="s10 softmerge" dir="ltr"><div class="softmerge-inner" style="width:198px;left:-1px">Vaginal delivery</div></td></tr><tr style="height: 20px"><th id="1050178152R25" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">26</div></th><td class="s11" dir="ltr">50–399 HIV RNA copies/mL</td><td class="s12 softmerge" dir="ltr"><div class="softmerge-inner" style="width:1098px;left:-1px">PLCS considered<br>Take into account the actual viral load, trajectory of viral load, length of time on treatment, adherence issues, obstetric factors and the womans views</div></td></tr><tr style="height: 20px"><th id="1050178152R26" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">27</div></th><td class="s9" dir="ltr">≥400 HIV RNA copies/mL</td><td class="s9" dir="ltr">PLCS</td></tr><tr style="height: 20px"><th id="1050178152R27" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">28</div></th><td></td><td></td></tr><tr style="height: 20px"><th id="1050178152R28" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">29</div></th><td class="s13" dir="ltr">References:</td><td></td></tr><tr style="height: 20px"><th id="1050178152R29" style="height: 20px;" class="row-headers-background"><div class="row-header-wrapper" style="line-height: 20px">30</div></th><td class="s9" dir="ltr">BHIVA</td><td class="s14 softmerge" dir="ltr"><div class="softmerge-inner" style="width:398px;left:-1px"><a target="_blank" href="https://www.bhiva.org/file/WrhwAPoKvRmeV/BHIVA-Pregnancy-guidelines-consultation-draft-final.pdf">Management HIV in Pregnancy 2018 guidelines</a></div></td></tr></tbody></table></div>